OIG: HHS Must Clamp Down on Off-Label Promotion

Drug Industry Daily
A A
Drugmakers could see a stronger crackdown on off-label promotion according to a new Office of Inspector General (OIG) report that directs HHS to focus on the practice.

To View This Article:

Login

Subscribe To Drug Industry Daily